California Public Employees Retirement System Mei Pharma, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q1 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.6 - $3.65 $546,520 - $767,230	-210,200 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$2.73 - $4.5 $53,797 - $88,677	-19,706 Reduced 8.57%	210,200 $721,000
Q4 2020 Feb 02, 2021	SELL	$2.6 - $3.32 $11,440 - $14,608	-4,400 Reduced 1.88%	229,906 $607,000
Q3 2020 Nov 05, 2020	BUY	$2.46 - $4.27 $13,530 - $23,484	5,500 Added 2.4%	234,306 $731,000
Q2 2020 Aug 12, 2020	BUY	$1.45 - $4.3 $261,153 - $774,455	180,106 Added 369.83%	228,806 $945,000

Q4 2019 Jan 27, 2020	BUY	$1.65 - $2.48 $80,355 - $120,776	48,700 New	48,700 $121,000

Others Institutions Holding MEIP

# of Institutions

Shares Held

Call Options Held

Put Options Held

Urban Wealth Management, LLC

2K
Shares

$5,577
0.0% of portfolio

View Full List

About MEI Pharma, Inc.

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $372M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

More about MEIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account